Cargando…
Merging Natural Products: Muraymycin–Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents
To overcome bacterial resistances, the need for novel antimicrobial agents is urgent. The class of so‐called nucleoside antibiotics furnishes promising candidates for the development of new antibiotics, as these compounds block a clinically unexploited bacterial target: the integral membrane protein...
Autores principales: | Niro, Giuliana, Weck, Stefanie C., Ducho, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756498/ https://www.ncbi.nlm.nih.gov/pubmed/32897546 http://dx.doi.org/10.1002/chem.202003387 |
Ejemplares similares
-
Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents
por: Wiegmann, Daniel, et al.
Publicado: (2016) -
Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit
por: Heib, Anna, et al.
Publicado: (2019) -
Synthesis of an Antimicrobial Enterobactin‐Muraymycin Conjugate for Improved Activity Against Gram‐Negative Bacteria
por: Rohrbacher, Christian, et al.
Publicado: (2022) -
Aminoribosylated Analogues of Muraymycin Nucleoside Antibiotics
por: Wiegmann, Daniel, et al.
Publicado: (2018) -
Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures
por: Spork, Anatol P., et al.
Publicado: (2018)